4B1F
Design of Inhibitors of Helicobacter pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty
Summary for 4B1F
Entry DOI | 10.2210/pdb4b1f/pdb |
Related | 2JFX 2JFY 2JFZ 2W4I |
Descriptor | GLUTAMATE RACEMASE, 5-methyl-3-(1-methyl-1H-imidazol-5-yl)-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione, D-GLUTAMIC ACID, ... (4 entities in total) |
Functional Keywords | isomerase, improved bioavailability |
Biological source | HELICOBACTER PYLORI |
Total number of polymer chains | 2 |
Total formula weight | 58243.67 |
Authors | Basarab, G.S.,Hill, P.,Eyermann, C.J.,Gowravaram, M.,Kack, H.,Osimoni, E. (deposition date: 2012-07-10, release date: 2012-07-18, Last modification date: 2018-05-02) |
Primary citation | Basarab, G.S.,Hill, P.,Eyermann, C.J.,Gowravaram, M.,Kack, H.,Osimoni, E. Design of Inhibitors of Helicobacter Pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles Onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty. Bioorg.Med.Chem.Lett., 22:5600-, 2012 Cited by PubMed: 22877632DOI: 10.1016/J.BMCL.2012.07.004 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.05 Å) |
Structure validation
Download full validation report